American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Element Solutions
ESI
$9.51B
| $94.7M | 0.08% |
5,320,955
-271,046
| -5% | -$5.5M |
|
277
Paylocity
PCTY
$7.67B
| $93.9M | 0.08% |
538,411
+59,017
| +12% | +$10.8M |
|
|
ABMD
278
DELISTED
Abiomed Inc
ABMD
| $93.7M | 0.08% |
378,421
+220,043
| +139% | +$59.4M |
|
|
PDCO
279
DELISTED
Patterson Companies, Inc.
PDCO
| $93.1M | 0.08% |
3,073,086
-159,596
| -5% | -$5M |
|
280
Ameris Bancorp
ABCB
$5.99B
| $91.9M | 0.08% |
2,287,708
+131,908
| +6% | +$5.6M |
|
281
Parker-Hannifin
PH
$134B
| $91.7M | 0.08% |
372,669
-33,351
| -8% | -$8.92M |
|
282
Trane Technologies
TT
$106B
| $90M | 0.07% |
693,155
+1,885
| +0.3% | +$261K |
|
283
Enphase Energy
ENPH
$5.35B
| $89.5M | 0.07% |
458,439
-228,459
| -33% | -$41.3M |
|
284
KLA
KLAC
$278B
| $89.4M | 0.07% |
2,801,690
+123,420
| +5% | +$4.15M |
|
285
Bank of America
BAC
$449B
| $88.9M | 0.07% |
2,856,310
-2,366,808
| -45% | -$85.2M |
|
286
Sarepta Therapeutics
SRPT
$1.94B
| $88.8M | 0.07% |
1,184,449
+365,376
| +45% | +$26.9M |
|
287
Insulet
PODD
$10B
| $88.1M | 0.07% |
404,412
+5,769
| +1% | +$1.31M |
|
288
Match Group
MTCH
$8.4B
| $87.8M | 0.07% |
1,259,550
+268,134
| +27% | +$21.7M |
|
289
Dycom Industries
DY
$12.5B
| $87.5M | 0.07% |
940,377
-275,467
| -23% | -$24.5M |
|
290
Biogen
BIIB
$31.1B
| $87.3M | 0.07% |
428,099
-451,703
| -51% | -$92.3M |
|
291
Pool Corp
POOL
$7.24B
| $86.9M | 0.07% |
247,350
+241,814
| +4,368% | +$95.9M |
|
292
American Century Multisector Income ETF
MUSI
$249M
| $86.7M | 0.07% |
1,973,189
| – | – |
|
|
PPBI
293
DELISTED
Pacific Premier Bancorp
PPBI
| $85.7M | 0.07% |
2,931,870
+137,273
| +5% | +$4.39M |
|
294
argenx
ARGX
$54B
| $85.6M | 0.07% |
225,910
-3,689
| -2% | -$1.19M |
|
295
IBM
IBM
$221B
| $85.6M | 0.07% |
606,155
+560,934
| +1,240% | +$75.7M |
|
296
Home BancShares
HOMB
$6.26B
| $85.2M | 0.07% |
4,102,075
+121,200
| +3% | +$2.62M |
|
297
EPAM Systems
EPAM
$5.15B
| $85M | 0.07% |
288,203
+46,809
| +19% | +$14.3M |
|
298
Copart
CPRT
$26.9B
| $84.7M | 0.07% |
3,119,764
+79,280
| +3% | +$2.26M |
|
299
Amcor
AMCR
$21.5B
| $84.5M | 0.07% |
1,359,011
-1,436,447
| -51% | -$88.8M |
|
300
Alnylam Pharmaceuticals
ALNY
$30.4B
| $83.9M | 0.07% |
574,941
-556,903
| -49% | -$79M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.